Category Venues

Sign Of The Times: USTR Press Events 100 Percent Closed To Press

How sensitive is US trade? Perhaps as an indication of its approach to the press, the United States Trade Representative's office yesterday published its weekly "press week ahead" full of events that would be of interest to domestic and international press - and 100 percent closed to press.

UPOV Holds Weeklong Meetings As Civil Society Publishes Restricted Documents

This week the International Union for the Protection of New Varieties of Plants (UPOV) is holding the annual meeting of its governing body, and preparatory meetings leading up to it. A seminar also is being held on essentially derived varieties. Meanwhile, civil society is asking that all the meeting documents be held public while demonstrating that restricted documents can be obtained through national freedom of information rights.

European Commission Market-Tests Samsung Antitrust Commitments

The European Commission wants feedback from interested parties on a proposal by Samsung Electronics to resolve an antitrust investigation. The case relates to Samsung's efforts to enforce standard essential patents (SEPs) it owns for mobile communications technology. SEPs are patents that protect technologies essential for the implementation of an industry standard developed by a standard-setting organisation.

IP Scores High In Sports – Supports Amateurs, Olympics, Development, Speakers Say

Alongside last week’s meeting of the World Trade Organization intellectual property committee, the United States, European Union and Jamaica organised an event on the relevance of intellectual property in sports. Speakers from professional organisations such as the International Olympic Committee, the Association of European Professional Football Leagues, and the Nike company were invited to share their experience in the matter.

GAVI: Reducing Prices To Immunise 250 Million Children By 2015

The GAVI Alliance launched a mid-term report this week showing that the public-private partnership is on track to immunise more than 250 million children by 2015 and prevent some four million deaths. GAVI’s CEO said it uses multiple tools to help reduce prices of vaccine and that intellectual property rights do not pose a serious threat to its success.